226 related articles for article (PubMed ID: 12911044)
21. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
[TBL] [Abstract][Full Text] [Related]
22. Ethics seminars: withdrawal of treatment in the emergency department--when and how?
Bookman K; Abbott J
Acad Emerg Med; 2006 Dec; 13(12):1328-32. PubMed ID: 16946286
[TBL] [Abstract][Full Text] [Related]
23. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
Schulz N; Püschel K; Turk EE
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
[TBL] [Abstract][Full Text] [Related]
24. A survey of the perspectives of patients who are seriously ill regarding end-of-life decisions in some medical institutions of Korea, China and Japan.
Ivo K; Younsuck K; Ho YY; Sang-Yeon S; Seog HD; Hyunah B; Kenji H; Xiaomei Z
J Med Ethics; 2012 May; 38(5):310-6. PubMed ID: 22252418
[TBL] [Abstract][Full Text] [Related]
25. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
Morgenweck CJ
Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
[TBL] [Abstract][Full Text] [Related]
26. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
[TBL] [Abstract][Full Text] [Related]
27. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
England R; England T; Coggon J
J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
[TBL] [Abstract][Full Text] [Related]
28. Deactivating the implantable cardioverter-defibrillator: a biofixture analysis.
Paola FA; Walker RM
South Med J; 2000 Jan; 93(1):20-3. PubMed ID: 10653059
[TBL] [Abstract][Full Text] [Related]
29. Discontinuing implantable cardiac devices & the ERDs.
Slosar JP
Health Care Ethics USA; 2005; 13(2):E2. PubMed ID: 16273741
[TBL] [Abstract][Full Text] [Related]
30. Legal aspects of end-of-life decisions in Italy: the penal relevance of the limitation of treatment in the terminally ill and the problem of causality by omission. The legal puzzle of end-of-life care in Italy: is therapeutic limitation in the terminally ill patients a crime of omission liable to prosecution?
Fabris EP; Piccinni M
Eur J Anaesthesiol Suppl; 2008; 42():58-65. PubMed ID: 18289418
[TBL] [Abstract][Full Text] [Related]
31. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
Pilkington BC
J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
[TBL] [Abstract][Full Text] [Related]
32. [Ten myths about withdrawal of mechanical ventilation in terminal patients].
Beca JP; Montes JM; Abarca J
Rev Med Chil; 2010 May; 138(5):639-44. PubMed ID: 20668821
[TBL] [Abstract][Full Text] [Related]
33. Ethical Analysis of Withdrawing Total Artificial Heart Support.
DeMartino ES; Wordingham SE; Stulak JM; Boilson BA; Fuechtmann KR; Singh N; Sulmasy DP; Pajaro OE; Mueller PS
Mayo Clin Proc; 2017 May; 92(5):719-725. PubMed ID: 28473036
[TBL] [Abstract][Full Text] [Related]
34. The ethics of withdrawing artificial food and fluid from terminally ill patients: an end-of-life dilemma for Japanese nurses and families.
Konishi E; Davis AJ; Aiba T
Nurs Ethics; 2002 Jan; 9(1):7-19. PubMed ID: 16010894
[TBL] [Abstract][Full Text] [Related]
35. Deactivation of pacemakers and implantable cardioverter-defibrillators.
Kramer DB; Mitchell SL; Brock DW
Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
[TBL] [Abstract][Full Text] [Related]
36. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
Marinskis G; van Erven L;
Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
[TBL] [Abstract][Full Text] [Related]
37. Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.
Wright GA; Klein GJ; Gula LJ
Curr Opin Cardiol; 2013 Jan; 28(1):43-9. PubMed ID: 23128499
[TBL] [Abstract][Full Text] [Related]
38. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
[TBL] [Abstract][Full Text] [Related]
39. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
[TBL] [Abstract][Full Text] [Related]
40. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.
Kramer DB; Kesselheim AS; Brock DW; Maisel WH
Heart Rhythm; 2010 Nov; 7(11):1537-42. PubMed ID: 20650332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
